This is ridiculous, the girl can raise her legs a foot. No significant improvement? Where is the article that states the doctor said this? Not sure what is considered improvement but looks significant to me.
I have had about all i can stand of this company, this stock and these ridiculous pumpers. Had money tied up in this garbage for over a year, started in eighties, bought more in sixties and forties. Nothing but disappointment and ridiculous losses. 31 cents, REALLY????? This garbage would need over 100% gain just to break even for me. Shame on me for getting sucked in by you paid boiler room pumpers. Oh Yeah, Great company!!! load the boat!!!! Thanks for the cheap shares!!!! Shut the *(&(^ up. Biotechs flying up left and right and we just continue the same downward spiral. When will you guys admit this scam garbage is just that, 20 cents, 10 cents. Absolutely disgusted.
market cap is 255 million, 383.5 million buyout, doesnt that put this below book value. approximate share price at book of 2.50 a share. Why is it tanking? I don't really understand the potential milestones in this deal, is that money they may not get?
This stock is wearing me out. One of the only stocks im holding long for over a year now, down almost 50% and sick and tired of everyone pumping this thing to extremes. Seriously, what is the huge event that is gonna blow this thing over a dollar that i've been hearing about for a year? i was brought to this stock by this Mensa character along with liqd. Luckily I got out of liqd over a dollar, im not seeing much better results with this. How long are these faithful longs planning on holding this thing? Years upon years for a possible double? No good news has done (^&*( for this stock since i've been on board. About to cut my losses and move on, its getting old, chart looks like *(&)(, market all time high and we are headed to 30's now. Unbelievable.
Why does this company have such a huge float? I have owned this stock on the losing side and just noticed the float is aroun 230M. Does this mean they have flooded the market with shares? Is this the reason this thing barely budges anytime their is good news? Believe me, I'm not short, just would like some explanation from one of the people who feels ONCS is going through the roof. That's a lot of shares that have to move.
You thieves got your 40 downgrade target, you've scared out a bunch of investors, your hit pieces have dropped us 20%. Are we good yet or do you need sub 40's to cover, being the greedy &*(^s you are. I was hoping SWIR would be less manipulated being one of the most solid investments i have found. Wrong.
you all are. Pumpers and bashers. Disgusting to know that the human race consists of people like you. Whether you are paid by KNDI to pump your BS, or paid by Mark Cuban to bash. Disgusting all around. Makes it so hard to invest in a company you believe in. What a bunch of trash. Either case is losing right now. This thing is one the fence, its not going to crash to 2, and it's not going to the moon anytime soon. As a planned long term investor, I am disgusted with the PPS being about what i started at a year ago for a company with explosive growth throughout the year. What a wasted year. Useless even looking on this message board anymore. I'm sure the shorts will have there way with this over the next couple months, i am l holding some long but had to sell off some today. sickening manipulated performance all around. OUT
Im long kndi and quite underwater on it. I believe in the company and feel that these short hit pieces are a setup to get the price down because they know this one will fly with repeated good earnings and expansion. My concern though is on analyst coverage. Also surprised me that at almost 50% drop from highs these crooks are claiming best short idea, maybe at 22, at 12 it's a little late to the party i would hope. I'm new this year to investing so perhaps someone serious could explain this to me about analyst coverage. Why does this stock have none? I have stocks much smaller and under the radar that have analyst coverage. Are there any other examples of great stocks that have run with no analyst coverage? It also seems to be a popular short attack point. You would think some firm would step up, and give it a rating and price target at this point. Any thoughts?
I have just started investing this year, and have held up ok this year until September and portfolio is down 33% since then, needing a 50% gain to get back even. Major contributor is GSAT. I have been hit on every small cap i own, but this one is ridiculous.
This kind of attack is new to me, and makes me wonder why anyone even invests their hard earned money in this crooked game when this can happen for no reason. How can one $%#hole take down over 50% value of a stock in a week because they give a short attack thesis on it. Nothing fundamentally has changed and it continues to drop. I thought averaging down at 2.40 was a great move, never imagined that this could continue this far.
I am so sick to my stomach by this months losses, I went to sell after hours like the rest of the sheeple falling into this ^*&9&holes games, then I looked at the chart and just couldnt do it. If i had been sitting out and just saw this stock at this price for no reason other then some guy and his crew short attacking it, I would be buying all i could. Ive seen drug companies fail phase II drug trials and not drop this much. Amazing. Then you have people waiting till 1.50 or 1.00.
I know this post does no good to the share price, just like GSAT's presentation did no good yesterday. From what I have seen this year, Shorts ALWAYS win. Thieving #$%$ legally stealing my money. Something tells me it is a bad move to hold any longer as somehow this will go further, but I will hold with hopes that the real value of GSAT prevails. Next time i even hear hint of a short bear attack, I will sell and wait to buy back at 75% of the discount. Too bad the crooked thieving way is the profitable way, just like breaking into someones home and stealing there belongings is more profitable then working hard and buying them with integrity pride.
Doing DD and investing long in companies you believe in is a joke.
All it takes is one hit piece. For some reason I thought it would be different this time. Similar to ONVO and INO, and now KNDI for the second time. I agree that long term we will do well. I have a large stake and am doing my best to hold, tough to watch all gains go away, but that's the game. To me, the chart looks like a range of 16 to 18 for a while and then a pop into new highs. Of course manipulation could change that.
Most are probably tired of the games. I know I am. Typical market manipulation by crooks to knock it down just like every stock that gets a run lately, followed by a week of intense bashing and intense pumping. The stock is getting tired. Hopefully it floats in this range instead of crashing back to lows like last time. I know a PR from the company would do wonders.
Just started investing end of 2013. I see countless stocks from last year that just climbed all year. Everytime i get a decent run on something, these hit pieces tear away my gains and sometimes turn to losses. Happened KNDI, ONVO, INO, and others. How did so many stocks just run in 2013? since I've started, no matter how good a company, these people come up with something and the street reacts to an extreme. It's like clockwork.
Same boat, bought at 14 and held through last pop to 22 to watch all my gains go and then turn to loss down to 10, I feel there is more support this time and the company is proving itself, but I'm never comfortable after that until this thing hits 25 plus. Sold some yesterday and waiting for reentry.
Agreed. Perfect cup, i sold some and am looking to pick back up in 18's on the handle before hitting new highs. Hard to be patient knowing it may not get that low. See what tomorrow brings.
Being new to biotech, what are we expecting from the trial update. I understand that it did not meet secondary endpoints, but there were some other improvements noted, are we waiting for an announcement of another phase II trial to be conducted with different expectations, or a phase III trial using the positive data from phase II for a different type of treatment? I'm not quite sure how it works. What are some possible catalysts from this update news. Its great that there were some other positive responses to this drug, but where does that take us being that it failed the phase II trials for what it was intended for. Any help would be appreciated.